Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

COVID-19: European regulator ready to approve first successful vaccine this year

Chike Olisah by Chike Olisah
July 22, 2020
in Coronavirus
Covid-19: UK Govt warns of new strain that spreads faster and may have already left the UK, New coronavirus mutation ten times more infectious has been discovered
Share on FacebookShare on TwitterShare on Linkedin

The first vaccine against the coronavirus disease could be approved by the European regulators this year, after a couple of trials by drugmakers leading the race showed encouraging results.

According to Bloomberg, the head of anti-infectives and vaccines at European Medicines Agency, Marco Cavaleri, said, ‘’We are preparing ourselves for that possibility so that we as regulators will be ready. It will be a matter of seeing whether this data could be sufficient for allowing any kind of approval by the end of 2020.”

Cavaleri said that the EMA will start working with drugmakers on a rolling review after the summer. He also said that trial data, manufacturing and clinical decisions will be assessed by the regulator in real-time to speed up the approval process. The approach should allow any successful vaccine to be officially approved within a matter of days once submitted.

RelatedPosts

World Bank says COVID-19 sparked surge in financial inclusion globally

US Vice President, Kamala Harris tests positive for COVID-19

The EMA has, however, refused to set a target on the efficacy needed for a vaccine, opting to wait until more data is available, unlike the US Food and Drug Administration (FDA). The FDA has said that any vaccine candidate shot would need to prevent disease or decrease severity in at least half of those vaccinated to earn approval.

Going further, Cavaleri said, ‘’For the time being it’s very difficult to define any threshold. We have to look at the benefit-risk of the vaccines once data become available and this precludes the possibility of being so definitive on what will be a minimal acceptable level of efficacy.”

News continues after this ad


READ MORE: Potential COVID-19 vaccine boost U.S stocks

The backstory

Recall that there has been growing optimism over prospects for developing a vaccine for COVID-19 following the publishing of positive results by University of Oxford and AstraZeneca Plc from early human tests of a shot on Monday. Vaccine partners Pfizer Inc. and BioNTech SE, as well as China-based CanSino Biologics Inc., also  announced early positive data from their own vaccine trials. AstraZeneca Chief Executive Officer Pascal Soriot said the company hopes to be able to start delivering a vaccine by the end of the year.

News continues after this ad


What this means

The race to get a vaccine approved by the end of the year would also avoid a potential Brexit headache for drugmakers. With effect from January, any shot would need to be approved by both the EMA and the U.K.’s Medicines and Healthcare Products Regulatory Agency. A representative for the MHRA said the agency was “prioritizing work to support the development of vaccines and medicines” to fight the pandemic.

Related

Tags: Covid-19US Food and Drug Administration (FDA)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

inq
avatrade
Stanbic bank
Mega Millions
UBN
Hot forex
Access Bank
Bankers Committee
First bank






    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • Delta Air flight to Lagos, Nigeria makes u-turn after plane developed fault in the air
    • Seplat and Mobil deal: It’s time to consider moving on
    • 24 Hours Power Supply: Ikeja Electric Sign Tripartite Agreement with Enaro Energy and Ayobo Community

    Follow us on social media:

    Recent News

    Delta Air flight to Lagos, Nigeria makes u-turn after plane developed fault in the air

    Delta Air flight to Lagos, Nigeria makes u-turn after plane developed fault in the air

    August 11, 2022
    Developing nations must be allowed to create a just energy transition – Roger Brown, Seplat CEO

    Seplat and Mobil deal: It’s time to consider moving on

    August 11, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com